Ankylosing Spondylitis News

News

Study Identifies Differences in Outpatients With AS and Axial PsA

08/20/2021

“Axial involvement affects 25% to 70% of PsA patients, depending on the criteria used for its definition,” wrote researchers from Athens, Greece. “Efforts are underway to clarify the similarities and differences between axial PsA and AS.”

“Axial involvement affects 25%...

08/20/2021

First Report Managed Care

News

AMA Votes Against Insurers Paying Patients to Switch Treatments

07/10/2021

Jolynn Tumolo ;

The American Medical Association (AMA) will support state and federal legislation to oppose insurance companies offering financial incentives for patients to switch from a prescribed treatment to a payer-preferred treatment following the...

The American Medical Association...

07/10/2021

First Report Managed Care

News

Self-Management for Inflammatory Arthritis Valuable, But Best Interventions Remain Vague

06/22/2021

Jolynn Tumolo ;

Self-management interventions are beneficial for patients with inflammatory arthritis, confirms a systematic review.

Self-management interventions...

06/22/2021

First Report Managed Care

News

Treatment Produces Clinically Meaningful Response in Active Ankylosing Spondylitis

05/06/2021

“Currently, the unmet need for treatment options is high in patients with ankylosing spondylitis, including a need for effective oral treatment options following NSAIDs and a need for additional mechanisms of action,” researchers wrote.

“Currently, the unmet need for...

05/06/2021

First Report Managed Care

News

As a Second Biologic for Spondyloarthritis, Treatment Shows High Retention Rates

04/21/2021

“Because persistence with the same anti-TNF drug in second-line treatment decreases the overall disease-associated costs compared with non-persistence, this aspect … merits consideration by physicians and payers when choosing a biological...

“Because persistence with the...

04/21/2021

First Report Managed Care

News

Biologic Strategies for Ankylosing Spondylitis Not Cost-Effective at Common Threshold

12/07/2020

No biologic strategies in treatment guidelines for ankylosing spondylitis were cost-effective at a willingness-to-pay threshold of $100,000 per quality-adjusted life-year.

No biologic strategies in...

12/07/2020

First Report Managed Care

News

Switching or Discontinuing Ankylosing Spondylitis Biologics Raises Medical Costs

10/31/2020

Patients with ankylosing spondylitis who switch or discontinue their biologic within a year of starting it have higher health care utilization and medical costs compared with patients who stay with their index biologic.

Patients with ankylosing...

10/31/2020

First Report Managed Care

News

Understanding the Link Between bDMARD Initiation, Switching With Mood Disorders

10/02/2020

Researchers found a positive association between the use of antidepressant and anxiolytic medication with both the introduction and switching of bDMARDs.

Researchers found a positive...

10/02/2020

First Report Managed Care

News

Disease Activity in Axial Spondylarthritis Patients Linked With Current State of Health Care Stress

09/22/2020

Researchers found that patients with axial spondyloarthritis who experienced higher levels of perceived stress and anxiety during the current shelter-in-place orders had significantly higher disease activity levels compared with patients with...

Researchers found that patients...

09/22/2020

First Report Managed Care

News

Ankylosing Spondylitis Improvement Sustained After 5 Years of Secukinumab Treatment

08/18/2020

A Phase III trial showed patients with ankylosing spondylitis experienced sustained improvement in signs, symptoms, and physical function after 5 years of treatment with subcutaneous secukinumab.

A Phase III trial showed...

08/18/2020

First Report Managed Care

Current Issue

September 2024

Volume 21

Issue 3

Current Issue

Issue Archive

What's Trending?

News

Virginia Senate Passes Medicaid Expansion

05/30/2018

The Virginia Senate narrowly voted to pass Medicaid expansion under the Affordable Care Act.

The Virginia Senate narrowly...

05/30/2018

First Report Managed Care

News

Questions swirl over safety of popular diabetes drug

06/23/2010

First Report Managed Care

January 2016 Issue Preview (Conference Insider)

12/20/2015

First Report Managed Care continues to be dedicated to providing important coverage of conferences affecting managed care professionals.

First Report Managed...

12/20/2015

First Report Managed Care

News

Drug firm payments to doctors declining

09/14/2011

First Report Managed Care

News

Almost 6.5 Million Signed Up for Health Insurance on Exchange

01/05/2015

Nearly 6.5 million people signed up for or were automatically reenrolled for a 2015 healthcare insurance plan via Healthcare.gov, as of December 26, 2014.

Nearly 6.5 million people signed...

01/05/2015

First Report Managed Care

Video Insights

Videos

Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care

11/13/2024

David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...

David Sand, MD, MBA, chief...

11/13/2024

First Report Managed Care

Videos

The Evolving Role of CGRP-targeting Therapies in Migraine Prevention

10/31/2024

Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.

Richard Lipton, MD, provides...

10/31/2024

First Report Managed Care

Videos

Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer

09/26/2024

Alexander Spira , MD, PhD;

Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).

Alexander I. Spira, MD, PhD,...

09/26/2024

First Report Managed Care

Videos

Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives

09/25/2024

Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.

Learn about research...

09/25/2024

First Report Managed Care

Videos

Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable

09/04/2024

View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.

View a roundtable discussion on...

09/04/2024

First Report Managed Care

Videos

Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions

08/15/2024

Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...

Guest expert Jordan Bazinsky...

08/15/2024

First Report Managed Care

Videos

Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia

08/14/2024

Farrukh T. Awan , MD;

Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).

Farrukh Awan, MD, highlights...

08/14/2024

Journal of Clinical Pathways

Videos

Evolving Health Care Contact Centers Into Drivers of Value-Based Care

07/31/2024

Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.

Discover how health care contact...

07/31/2024

First Report Managed Care

Videos

Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024

06/11/2024

Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations

Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...

Key stakeholders in the health...

06/11/2024

First Report Managed Care

Melissa Andel, Principal, CommonHealth Solutions, LLC

Videos

Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers

05/24/2024

Melissa Andel, Principal, CommonHealth Solutions, LLC

Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.

Ankylosing Spondylitis News

Current Issue

What's Trending?

Video Insights

Subscribe to our eNewsletters!

Specialties

Events

Year Round Education

HMP Global Products